In control animals, where CD8+ T cells are present, CA170 treatment significantly inhibited the metastasis of lung cancer, this inhibitory effect was decreased by CD8 depletion (Fig. 2C), as evidenced by the increase in the tumor burden in lung (Fig. 2C). The gene discussed is CD8A; the disease is lung carcinoma.